In this Pullan’s Pieces webinar, the third in the series, business development consultant, Linda Pullan, PhD, will present an overview of the inflammation therapeutics landscape. This will include snapshots of diseases, unmet needs, sales of top drugs and forecasts, drugs in development, top molecular targets, venture and licensing deals.
What you’ll learn:
- Where is inflammation drug development focused
- What are popular targets
- Where are the big sales and what is forecast
- Who have been active deal makers
- What’s to come in the next few years
Join us for a wide-range examination of the inflammatory therapeutics landscape including clarity and perspective on the complexities and nuances.
Attendees will have the opportunity to ask questions during and after the discussion. Can’t attend? Sign up and we’ll send you the recording.